200 related articles for article (PubMed ID: 9363724)
1. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
[TBL] [Abstract][Full Text] [Related]
2. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
[TBL] [Abstract][Full Text] [Related]
3. Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist.
Kettel LM; Murphy AA; Morales AJ; Rivier J; Vale W; Yen SS
Fertil Steril; 1993 Oct; 60(4):642-6. PubMed ID: 8405517
[TBL] [Abstract][Full Text] [Related]
4. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.
Felberbaum RE; Germer U; Ludwig M; Riethmüller-Winzen H; Heise S; Buttge I; Bauer O; Reissmann T; Engel J; Diedrich K
Hum Reprod; 1998 Jun; 13(6):1660-8. PubMed ID: 9688409
[TBL] [Abstract][Full Text] [Related]
5. Pre-surgical treatment of uterine myomas with LH-RH agonists.
D'Addato F; Repinto A; Andreoli C
Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
7. Use of gonadotropin-releasing hormone agonists before myomectomy.
Friedman AJ
Clin Obstet Gynecol; 1993 Sep; 36(3):650-9. PubMed ID: 8403611
[No Abstract] [Full Text] [Related]
8. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study.
Engel JB; Audebert A; Frydman R; Zivny J; Diedrich K
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):225-32. PubMed ID: 16930803
[TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix].
Felberbaum RE; Ludwig M; Diedrich K
Contracept Fertil Sex; 1999 Oct; 27(10):701-9. PubMed ID: 10605180
[TBL] [Abstract][Full Text] [Related]
10. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix.
Flierman PA; Oberyé JJ; van der Hulst VP; de Blok S
BJOG; 2005 May; 112(5):638-42. PubMed ID: 15842290
[TBL] [Abstract][Full Text] [Related]
11. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative management of uterine leiomyomatosis using pituitary gonadotropin-releasing hormone analogues].
Bustos López HH; Miranda Rodríguez JA; Kably Ambe A; Serviere Zaragoza C; Espinoza de los Monteros A; Alvarado Durán A
Ginecol Obstet Mex; 1995 Aug; 63():356-64. PubMed ID: 7672654
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
Stovall TG; Ling FW; Henry LC; Woodruff MR
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
[TBL] [Abstract][Full Text] [Related]
15. Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).
Albano C; Smitz J; Camus M; Riethmüller-Winzen H; Siebert-Weigel M; Diedrich K; Van Steirteghem AC; Devroey P
Hum Reprod; 1996 Oct; 11(10):2114-8. PubMed ID: 8943511
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Friedman AJ; Lobel SM; Rein MS; Barbieri RL
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.
Comaru-Schally AM; Brannan W; Schally AV; Colcolough M; Monga M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3826-31. PubMed ID: 9814453
[TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy before surgical treatment for uterine leiomyomas.
Moghissi KS
Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
[TBL] [Abstract][Full Text] [Related]
19. Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas.
De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS
Hum Reprod; 1997 Feb; 12(2):357-60. PubMed ID: 9070725
[TBL] [Abstract][Full Text] [Related]
20. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.
Checa MA; Prat M; Robles A; Carreras R
Fertil Steril; 2006 Mar; 85(3):573-7. PubMed ID: 16500321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
